PROMETHEUS LABORATORIES, INC. v. ROXANE LABORATORIES, INC. (Fed. Cir. 2015) (P) – It is obvious to treat a subset of patients with an otherwise known procedure without unexpected results

It is generally obvious to treat a limited subset of patients with an otherwise known procedure when there are no unexpected results directly attributable to the patient subset itself. Here, for example, limiting the patient pool for a drug treating irritable bowel...